ACET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Adicet Bio Inc (ACET) is not a strong buy at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, lacks recent positive news or catalysts, and has weak financial performance. While analysts maintain a Buy rating, recent price target reductions and the absence of proprietary trading signals suggest caution.
The stock exhibits bearish technical indicators: MACD is below 0 and negatively contracting, RSI is neutral at 35.475, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The current price is near the support level of 6.577, with resistance at 7.038.
NULL identified. Analysts note a 'catalyst-rich calendar' for 2026, but there are no immediate events or news driving positive sentiment.
The stock recently underwent a reverse stock split to maintain NASDAQ listing requirements, which can indicate financial instability. Additionally, the company reported a significant net income loss (-$30.52M) and declining EPS (-12.45% YoY).
In Q4 2025, the company reported no revenue growth (0% YoY), a net income loss of -$30.52M (up 6.23% YoY), and a drop in EPS to -4.43 (-12.45% YoY). Gross margin remains at 0%.
Analysts maintain a Buy rating but have significantly lowered price targets recently. H.C. Wainwright reduced its target to $27 from $50, and Guggenheim reduced its target to $100 from $128, citing higher operating expenses and a reverse stock split.
